Hi, I’m Sandy Nguyen.
I'm a commercial strategist with 12+ years in drug development, building and executing commercial strategy across multiple pre-launch programs in specialty and orphan disease. Rebuilding my scientific foundation from scratch across those disciplines has trained me to orient quickly in new therapeutic areas and connect value to unmet need.
My experience has also given me a clear view of a persistent pattern: projects deprioritized because value wasn't communicated to the right person at the right time. I've watched novel treatments lose out to safer bets. I've seen transformative opportunities sit unrecognized while smaller, more immediate wins got funded.
My thesis is simple: innovation needs good marketing to ensure it attracts the interest and investment required to reach patients.
My Perspective
I draw on 12+ years of building and executing commercial strategy to examine why some ideas make it and others don't, and the common obstacles that stand in the way. The answer is rarely the quality of the strategy itself, but rather the gap between a sound recommendation and the organizational will, clarity, and execution to act on it. That gap usually lives at the top — in the judgment, self-awareness, and priorities of the people with decision-making authority. Culture doesn't just determine whether a strategy gets executed, but also whether the right strategy is adopted in the first place. Marketing is fundamentally about understanding people, and that curiosity has to exist inside the organization before it can be directed outward. Analytical rigor and human intelligence are required, and most organizations underinvest in one or the other.